These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3678302)

  • 1. The role of chemotherapy in the treatment of penile metastases from carcinoma of the bladder.
    Matthewman PJ; Oliver RT; Woodhouse CR; Tiptaft RC
    Eur Urol; 1987; 13(5):310-2. PubMed ID: 3678302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metastatic penile lesions secondary to transitional cell carcinoma of the bladder: a rare cause of "malignant priapism"].
    Casoli E; Di Fiore F; Longobardi S; Intilla O; Pone D
    Arch Ital Urol Androl; 2002 Mar; 74(1):48-9. PubMed ID: 12053452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastases to the corpora cavernosa from transitional cell carcinoma of the bladder.
    Haddad FS; Kivirand AI
    J Surg Oncol; 1986 May; 32(1):19-21. PubMed ID: 3724186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Penile metastasis from bladder cancer. A case report].
    Gentile V; Mariotti G; Fattore F; Cardi A; Di Silverio F
    Minerva Urol Nefrol; 2002 Jun; 54(2):129-30. PubMed ID: 12070461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of urothelial carcinoma associated with penile metastasis].
    Horinaga M; Kosugi M; Ikeuchi K
    Hinyokika Kiyo; 1999 Oct; 45(10):713-5. PubMed ID: 10586366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
    Koch MO; Coussens D
    Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
    [No Abstract]   [Full Text] [Related]  

  • 7. [Penile and urethral metastases from superficial bladder tumor after TUR: a case report].
    Takahashi S; Ozono S; Cho M; Fujimoto K; Sasaki K; Hirao Y; Okajima E
    Hinyokika Kiyo; 1989 Jun; 35(6):1055-9. PubMed ID: 2801393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of carcinomatous meningitis from transitional cell carcinoma of the bladder.
    Raghavan D; Chye RW
    Br J Urol; 1991 Apr; 67(4):438-40. PubMed ID: 2032089
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combination chemotherapy with cisplatin and methotrexate in advanced bladder cancer].
    Kobayashi K; Komatsu H; Takihana Y; Shirasu N; Tanabe N; Ishihama T; Takei K; Yamada Y; Ueno A
    Nihon Hinyokika Gakkai Zasshi; 1986 Jul; 77(7):1182-7. PubMed ID: 3784207
    [No Abstract]   [Full Text] [Related]  

  • 10. [Systemic chemotherapy in advanced bladder cancer. New aspects].
    Jakse G
    Wien Klin Wochenschr; 1987 Jan; 99(2):54-7. PubMed ID: 3564487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penile metastasis arising from transitional cell carcinoma of the urinary bladder.
    Khan MA; Tao W; Mathews P; Potluri BS
    Urol Int; 2001; 66(3):162-3. PubMed ID: 11316981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-line chemotherapy in advanced bladder cancer.
    Pavone-Macaluso M; Sternberg C
    Urol Int; 2000; 64(2):61-9. PubMed ID: 10810266
    [No Abstract]   [Full Text] [Related]  

  • 13. Transitional cell carcinomatous meningitis after M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) chemotherapy.
    Bishop JR; Moul JW; Maldonado L; McLeod DG
    Urology; 1990 Oct; 36(4):373-7. PubMed ID: 2219624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large cerebellar lesion as original manifestation of transitional cell carcinoma of the bladder.
    Davies BJ; Bastacky S; Chung SY
    Urology; 2003 Oct; 62(4):749. PubMed ID: 14550465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin for locally advanced transitional cell carcinoma of the bladder.
    Miller RJ; Bahnson RR; Banner B; Ernstoff MS; O'Donnell WF
    Cancer; 1990 Jan; 65(2):207-10. PubMed ID: 2295043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MVAC for bladder cancer: time to move forward again.
    Levine EG; Raghavan D
    J Clin Oncol; 1993 Mar; 11(3):387-9. PubMed ID: 8445412
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma.
    Hsu CH; Chen J; Wu CY; Cheng AL; Pu YS
    Anticancer Res; 2001; 21(1B):711-5. PubMed ID: 11299831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: a Northern California Oncology Group study.
    Meyers FJ; Palmer JM; Freiha FS; Harker EG; Shortliffe LD; Hannigan J; McWhirter K; Torti FM
    J Urol; 1985 Dec; 134(6):1118-21. PubMed ID: 3903223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complete remission of brain metastasis of bladder cancer treated by M-VAC therapy].
    Nakagawa S; Nakao M; Toyoda K; Nukui M; Takada H; Ebisui K
    Hinyokika Kiyo; 1989 Feb; 35(2):333-5. PubMed ID: 2735244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase-II study of neoadjuvant chemotherapy in T3-4N0-XM0 transitional cell carcinoma of the bladder: a preliminary analysis.
    Splinter TA; Schröder FH; Denis L; Newling D; Jacqmin D; Hall RR; de Pauw M
    Eur Urol; 1988; 14 Suppl 1():24-6. PubMed ID: 3181236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.